Literature DB >> 10825384

Coupling of I(1) imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline.

H Greney1, P Ronde, C Magnier, F Maranca, C Rascente, W Quaglia, M Giannella, M Pigini, L Brasili, C Lugnier, P Bousquet, M Dontenwill.   

Abstract

Clonidine and benazoline are two structurally related imidazolines. Whereas clonidine binds both to alpha(2)-adrenoceptors (alpha(2)R) and to I(1) imidazoline receptors (I(1)R), benazoline showed a high selectivity for imidazoline receptors. Although the alpha(2)R are negatively coupled to adenylate cyclase, no effect on cAMP level by activation of I(1)R has been reported so far. We therefore aimed to compare the effects of clonidine and benazoline on forskolin-stimulated cAMP levels in cell lines expressing either I(1)R only (PC12 cells), alpha(2)R only (HT29 cells), or I(1)R and alpha(2)R together (NG10815 cells). Clonidine proved able to decrease the forskolin-stimulated cAMP level in the cells expressing alpha(2)R and this effect could be blocked by rauwolscine. In contrast, in cells lacking these adrenoceptors, clonidine had no effect. On the other hand, benazoline and other I(1) receptor-selective imidazolines decreased forskolin-stimulated cAMP level in the cells expressing I(1)R, in a rauwolscine- and pertussis toxin-insensitive manner. These effects were antagonized by clonidine. According to these results, we demonstrated that 1) alpha(2)R and I(1)R are definitely different entities because they are expressed independently in different cell lines; 2) alpha(2)R and I(1)R are both implicated in the cAMP pathway in cells (one is sensitive to pertussis toxin and the other is not); and 3) I(1)R might be coupled to more then one transduction pathway. These new data will be essential to further understand the physiological implications of the I(1)R and the functional interactions between I(1) receptors and alpha(2)-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825384

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs.

Authors:  V Bruban; J Feldman; H Greney; M Dontenwill; S Schann; C Jarry; M Payard; J Boutin; E Scalbert; B Pfeiffer; P Renard; P Vanhoutte; P Bousquet
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation.

Authors:  Fabio Del Bello; Valentina Bargelli; Carlo Cifani; Paola Gratteri; Carla Bazzicalupi; Eleonora Diamanti; Mario Giannella; Valerio Mammoli; Rosanna Matucci; Maria Vittoria Micioni Di Bonaventura; Alessandro Piergentili; Wilma Quaglia; Maria Pigini
Journal:  ACS Med Chem Lett       Date:  2015-04-03       Impact factor: 4.345

3.  Imidazoleacetic acid-ribotide in vestibulo-sympathetic pathway neurons.

Authors:  Gay R Holstein; Victor L Friedrich; Giorgio P Martinelli
Journal:  Exp Brain Res       Date:  2016-07-13       Impact factor: 1.972

4.  LNP 906, the first high-affinity photoaffinity ligand selective for I1 imidazoline receptors.

Authors:  Dragan Urosevic; Urosevic Dragan; Stephan Schann; Schann Stephan; Jean-Daniel Ehrhardt; Ehrhardt Jean-Daniel; Pascal Bousquet; Bousquet Pascal; Hugues Greney; Greney Hugues
Journal:  Br J Pharmacol       Date:  2004-06       Impact factor: 8.739

5.  Presynaptic I1-imidazoline receptors reduce GABAergic synaptic transmission in striatal medium spiny neurons.

Authors:  Mitsuo Tanabe; Yurika Kino; Motoko Honda; Hideki Ono
Journal:  J Neurosci       Date:  2006-02-08       Impact factor: 6.167

6.  The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity.

Authors:  Laura Micheli; Lorenzo Di Cesare Mannelli; Fabio Del Bello; Mario Giannella; Alessandro Piergentili; Wilma Quaglia; Donatello Carrino; Alessandra Pacini; Carla Ghelardini
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

7.  Antineoplastic activity of idazoxan hydrochloride.

Authors:  G F Eilon; L Weisenthal; M Stupecky; G Landucci; L M Slater
Journal:  Cancer Chemother Pharmacol       Date:  2009-03-24       Impact factor: 3.333

8.  Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.

Authors:  Andrea Williams; Sovan Sarkar; Paul Cuddon; Evangelia K Ttofi; Shinji Saiki; Farah H Siddiqi; Luca Jahreiss; Angeleen Fleming; Dean Pask; Paul Goldsmith; Cahir J O'Kane; Rodrigo Andres Floto; David C Rubinsztein
Journal:  Nat Chem Biol       Date:  2008-05       Impact factor: 15.040

9.  Stimulation of alpha2-adrenergic receptors impairs influenza virus infection.

Authors:  Ken Matsui; Makoto Ozawa; Maki Kiso; Makoto Yamashita; Toshihiko Maekawa; Minoru Kubota; Sumio Sugano; Yoshihiro Kawaoka
Journal:  Sci Rep       Date:  2018-03-15       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.